Combo Therapy vs Monotherapy for Postmenopausal OsteoporosisCombo Therapy vs Monotherapy for Postmenopausal Osteoporosis

The combination of denosumab and teriparatide improves bone microarchitecture and estimated strength more than either drug alone in women with severe postmenopausal osteoporosis, researchers have found. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news